RADIATION ONCOLOGY AND ITS ROLE IN CANCER TREATMENT IN RURAL CANCER PATIENTS OF A CANCER CENTRE OF EASTERN INDIA: EVALUATING FEASIBILITY, COST-BENEFIT AND OUTCOMES.
Main Article Content
Keywords
Radiation Oncology, Rural Healthcare, Cancer Treatment, Socio-economic Barriers, Treatment Access.
Abstract
Cancer has become a major health problem in rural India, where a shortage of healthcare services exacerbates the impact of the disease. Radiation therapy is critical in the treatment of cancer; however, its underuse in rural settings largely results from financial, logistical, and psychosocial constraints.
AIMS AND OBJECTIVES: The purpose of this study was to assess the accessibility, efficacy, and socio-economic effect of radiation therapy among cancer patients in rural India.
METHODOLOGY: A retrospective cohort analysis compared 1,240 cancer patients and their treatment outcomes and cost benefit by data collection from departmental record files and contact details of the patients registered at our cancer centre in the year 2021.
RESULT: According to the findings, 570 of the patients were treated with radiation therapy and had 3-year survival rates of 70% in cases of breast cancer patients treated with radical radiation. Cost and fear of side effects were the two major reasons for refusing treatment.
CONCLUSION: The study showed that expanded radiation therapy access in rural areas is attainable by overcoming infrastructural shortcomings, cutting down economic expenses, and offering psychosocial support for better patient education and treatment compliance. The findings emphasize the need for embracing strategic interventions towards enhancing healthcare provision and the uptake of treatment in rural areas.
References
2. Chauhan AS, Prinja S, Ghoshal S, Verma R, Oinam AS. Cost of treatment for head and neck cancer in India. PLoS One. 2018;13(1):e0191132.
3. Chandralekha K. Economic evaluation and assessment of early toxicity of hypofractionated radiotherapy compared to standard fractionation in breast cancer. [Doctoral dissertation]. Christian Medical College, Vellore; 2015.
4. Gupta N, Chugh Y, Chauhan AS, Pramesh CS, Prinja S. Cost-effectiveness of Post-Mastectomy Radiotherapy (PMRT) for breast cancer in India: an economic modelling study. Lancet Regional Health-Southeast Asia. 2022;4.
5. Sinha S, Laskar SG, Wadasadawala T, et al. Adopting health economic research in radiation oncology: A perspective from low-or middle-income countries. JCO Global Oncol. 2022;8:e2100374.
6. Gelband H, Sankaranarayanan R, Gauvreau CL, et al. Costs, affordability, and feasibility of an essential package of cancer control interventions in low-income and middle-income countries: key messages from Disease Control Priorities. Lancet. 2016;387(10033):2133-2144.
7. Mbhele MM. Investigating the Economic Benefit of Better Access to Radiation Therapy Treatment to Women with Cervical Cancer in Rural KwaZulu-Natal, South Africa. [Doctoral dissertation]. Durban, 2017.
8. Deo SV, Pramanik R, Chaturvedi M, et al. Telemedicine and cancer care in India: promises, opportunities, and caveats. Future Sci OA. 2022;8(9):FSO821.
9. Rosenblatt E, Zubizarreta E, eds. Radiotherapy in Cancer Care: Facing the Global Challenge. Vienna: International Atomic Energy Agency; 2017:80112-6.
10. Chintapally N, Nuwayhid M, Arroju V, et al. State of cancer care in India and opportunities for innovation. Future Oncol. 2023;19(39):2593-2606.
11. Shahjalal M, Sultana M, Gow J, et al. Assessing health-related quality of life among cancer survivors during systemic and radiation therapy in Bangladesh: a cancer-specific exploration. BMC Cancer. 2023;23(1):1208.
12. Haier J, Schaefers J. Economic perspective of cancer care and its consequences for vulnerable groups. Cancers. 2022;14(13):3158.
13. Kraus RD, Weil CR, Abdel-Wahab M. Benefits of adopting hypofractionated radiotherapy as a standard of care in low-and middle-income countries. JCO Global Oncol. 2022;8:e2200215.
14. Horton S, Gauvreau CL. Cancer in low-and middle-income countries: an economic overview. Cancer: Disease Control Priorities. 2015;3:263-280.
15. Beltrán Ponce SE, Abunike SA, Bikomeye JC, et al. Access to radiation therapy and related clinical outcomes in patients with cervical and breast cancer across sub-Saharan Africa: a systematic review. JCO Global Oncol. 2023;9:e2200218.
16. Hande V, Ranjan N, Chopra S, et al. Longitudinal costs of image-guided intensity-modulated radiation therapy versus three-dimensional conformal radiation: lessons from phase III PARCER trial for shaping resource-stratified guidelines in low-and middle-income countries. JCO Global Oncol. 2024;10:e2300478.
17. Sullivan R, Alatise OI, Anderson BO, et al. Global cancer surgery: delivering safe, affordable, and timely cancer surgery. Lancet Oncol. 2015;16(11):1193-1224.
18. Bray F, Jemal A, Torre LA, Forman D, Vineis P. Long-term realism and cost-effectiveness: primary prevention in combating cancer and associated inequalities worldwide. J Natl Cancer Inst. 2015;107(12):djv273.
19. Aggarwal G, Aggarwal SK. Evolution and progress in the application of radiation in cancer diagnosis and therapy. Curr Sci. 2017:413-421.
20. Mao JJ, Pillai GG, Andrade CJ, et al. Integrative oncology: Addressing the global challenges of cancer prevention and treatment. CA Cancer J Clin. 2022;72(2):144-164.
21. Donkor A. Access to Radiotherapy for Cancer Treatment (ARC) Project: Guidance for Low and Middle-Income Countries Establishing Safe and Sustainable Radiotherapy Services. University of Technology Sydney; 2020.
22. Atieno OM, Opanga S, Martin A, Kurdi A, Godman B. Pilot study assessing the direct medical cost of treating patients with cancer in Kenya; findings and implications for the future. J Med Econ. 2018;21(9):878-887.
23. Jiwnani S, Penumadu P, Ashok A, Pramesh CS. Lung cancer management in low and middle-income countries. Thorac Surg Clin. 2022;32(3):383-395.
24. Bamodu OA, Chung CC. Cancer care disparities: overcoming barriers to cancer control in low-and middle-income countries. JCO Global Oncol. 2024;10:e2300439.
25. Abdel-Wahab M, Giammarile F, Carrara M, et al. Radiotherapy and theranostics: a Lancet Oncology commission. Lancet Oncol. 2024;25(11):e545-e580.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Anindya Sarkar
Assistant Professor, Department of Radiotherapy, Murshidabad Medical College Hospital, Berhampore, West Bengal, India.
Subhayan Saha
Senior Resident, Department of Radiotherapy, Chittaranjan National Cancer Institute (CNCI), Kolkata, West Bengal, India.